Style | Citing Format |
---|---|
MLA | Jalali A, Dabaghian F, Zarshenas MM. "Alkaloids of Peganum Harmala: Anticancer Biomarkers With Promising Outcomes." Current Pharmaceutical Design, vol. 27, no. 2, 2021, pp. 185-196. |
APA | Jalali A, Dabaghian F, Zarshenas MM (2021). Alkaloids of Peganum Harmala: Anticancer Biomarkers With Promising Outcomes. Current Pharmaceutical Design, 27(2), 185-196. |
Chicago | Jalali A, Dabaghian F, Zarshenas MM. "Alkaloids of Peganum Harmala: Anticancer Biomarkers With Promising Outcomes." Current Pharmaceutical Design 27, no. 2 (2021): 185-196. |
Harvard | Jalali A, Dabaghian F, Zarshenas MM (2021) 'Alkaloids of Peganum Harmala: Anticancer Biomarkers With Promising Outcomes', Current Pharmaceutical Design, 27(2), pp. 185-196. |
Vancouver | Jalali A, Dabaghian F, Zarshenas MM. Alkaloids of Peganum Harmala: Anticancer Biomarkers With Promising Outcomes. Current Pharmaceutical Design. 2021;27(2):185-196. |
BibTex | @article{ author = {Jalali A and Dabaghian F and Zarshenas MM}, title = {Alkaloids of Peganum Harmala: Anticancer Biomarkers With Promising Outcomes}, journal = {Current Pharmaceutical Design}, volume = {27}, number = {2}, pages = {185-196}, year = {2021} } |
RIS | TY - JOUR AU - Jalali A AU - Dabaghian F AU - Zarshenas MM TI - Alkaloids of Peganum Harmala: Anticancer Biomarkers With Promising Outcomes JO - Current Pharmaceutical Design VL - 27 IS - 2 SP - 185 EP - 196 PY - 2021 ER - |